Abstract:While the benefit and risk of estrogen replacement therapy for cardiovascular disease remains controversial, women frequently choose alternatives to estrogen such as phytoestrogen for treatment of menopause even though medical indications for estrogens may exist. Phytoestrogens also possess distinct advantages over mammalian estrogens because their usage in men without feminizing side effects. Nevertheless, the cardiac contractile function of estrogen or phytoestrogen has not been clearly elucidated. The aim of the present study was to compare the effect of 17β estradiol (E 2 ) and phytoestrogen α-zearalanol (ZAL) on cardiac mechanical function and intracellular Ca 2+ transients at cellular levels. Isolated ventricular myocytes from adult female rats were stimulated to contract at 0.5 Hz. Contractile properties were evaluated using an IonOptix MyoCam® system including peak shortening (PS), time-to-PS (TPS), time-to-90% relengthening (TR 90 ), and maximal velocity of shortening/relengthening (± dL/dt). Intracellular Ca 2+ properties were evaluated as fura-2 fluorescent intensity change (ΔFFI) and intracellular Ca 2+ decay rate. Acute administration of E 2 (10 −9 –10 −5 M ) elicited a concentration-dependent increase in PS and ΔFFI, with maximal augmentation of approx 35% and 25%, respectively. TPS, TR 90 , ± dL/dt, resting intracellular Ca 2+ level, and intracellular Ca 2+ decay were unaffected by E 2 . None of the mechanical or intracellular Ca 2+ indices tested was affected by phytoestrogen ZAL (10 −9 –10 −5 M ). Our results revealed a direct cardiac stimulatory action from E 2 but not from phytoestrogen ZAL on ventricular contraction, likely mediated through enhanced intracellular Ca 2+ release.

Comparison of cardiac contractile and intracellular Ca 2+ response between estrogen and phytoestrogen α-zearalanol in ventricular myocytes